Today in FirstWord: Merck & Co., Gilead Sciences, AstraZeneca, Bristol-Myers Squibb, Padlock Therapeutics

Today in FirstWord: Merck &amp; Co., Gilead Sciences, AstraZeneca, Bristol-Myers Squibb, Padlock Therapeutics

FirstWord Pharmaceutical News for Wednesday, Mar 23, 2016

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional.  For more information on this time-saving tool, please visit www.firstwordpharma.com.

Business

Medicine

Business News

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional. For more information on this time-saving tool, please visit www.firstwordpharma.com.

Share FirstWord Pharmaceutical News for Wednesday, Mar 23, 2016

Sign up to save your podcasts

FirstWord Pharmaceutical News for Wednesday, Mar 23, 2016

FirstWord Pharmaceutical News for Wednesday, Mar 23, 2016